角膜塑形鏡市場－2026-2031年預測

角膜塑形鏡市場預計將從 2025 年的 870,785,000 美元成長到 2031 年的 1,251,210,000 美元，複合年成長率為 6.23%。

角膜塑形鏡（Ortho-K）市場是隱形眼鏡和視力矯正行業中一個快速成長的專業細分市場，專注於設計、製造和驗配過夜佩戴的硬式高透氧（RGP）隱形眼鏡。這些鏡片透過可控制的塑形製程暫時再形成角膜曲率，使患者在摘除鏡片後，白天仍能擁有清晰的無眼鏡視力。角膜塑形鏡主要用於矯正近視，對矯正遠視和散光也有一定的效果，它為雷射手術提供了一種非手術、可逆的替代方案。全球近視盛行率的上升、患者對非手術治療方法的偏好日益成長，以及角膜塑形鏡在延緩兒童近視進展方面的獨特提案，都推動了該市場顯著成長，使其成為一項重要的臨床應用。

核心技術及作用機制

角膜塑形術採用反向幾何鏡片設計。與直接屈光光線矯正視力的標準隱形眼鏡不同，角膜塑形鏡會在您睡眠時對角膜中央施加輕柔的壓力。這會暫時改變上皮細胞的排列，使中央光學區域變平，從而減少近視屈光不正。這種效果並非永久性的；角膜的彈性使其能夠逐漸恢復到原來的形狀。因此，通常需要每晚佩戴才能維持矯正視力。整個過程由眼科專業人員透過一系列的驗配和後續觀察精心管理，以確保安全、有效並獲得最佳的視覺效果。

近視的預防和控制是角膜塑形鏡一項重要且日益成長的應用領域。臨床研究表明，特定設計的角膜塑形鏡能夠有效延緩兒童和青少年近視的發展進程。這使得角膜塑形鏡成為治療兒童近視的主要選擇之一，有效緩解了家長和眼科專業人士對近視率上升及其相關長期眼部健康風險的擔憂。

主要市場促進因素

主要促進因素是全球近視盛行率的不斷上升，尤其是在兒童和青少年群體中。與生活方式因素相關的流行病學趨勢，例如近距離工作增加和戶外活動減少，導致尋求矯正視力的患者人數不斷成長。這種「近視熱潮」在亞太地區尤其顯著，但其實是一種全球現象。

與此密切相關的是，人們對減緩近視進展的解決方案的需求日益成長。隨著眼科專業人員和家長越來越意識到高度近視相關的風險（例如視網膜剝離、青光眼和近視性黃斑病變），角膜塑形術（Ortho-K）已被積極應用於減緩兒童眼軸成長的主要干預措施，從而加快了新鏡片驗配和更換週期。

另一個重要因素是患者傾向於選擇非手術、可逆的視力矯正方式。角膜塑形術在不適合或不願接受屈光矯正手術（如雷射近視手術）的人群中很受歡迎（例如，年輕患者、角膜較薄的患者或從事手術禁忌職業的患者）。無需戴眼鏡即可輕鬆出行，這無疑是一項重要的生活方式優勢。

另一個促成因素是全球人口老化，老花眼（與老齡化相關的近距離視力喪失）可能與現有的屈光不正相結合，造成複雜的視力矯正需求，而這些需求可以透過專門的多焦點角膜塑形鏡設計來解決。

市場挑戰與限制因素

阻礙該療法廣泛應用的主要障礙在於其高昂的前期投入和持續費用：包括專用診斷設備、專業驗配費用以及鏡片本身的成本，後者遠高於普通軟式隱形眼鏡。這會限制其普及，尤其是在價格敏感型市場或缺乏健保覆蓋的地區。

治療需要患者高度配合和高超的專業技能。堅持夜間配戴和細緻的鏡片清潔是取得良好治療效果的關鍵，有助於降低微生物性角膜炎和其他疾病的風險。與一般隱形眼鏡相比，驗配過程更為複雜耗時，需要經過專門培訓和經驗豐富的醫護人員，這可能會限制可開立處方的醫生數量。

區域市場動態

北美是一個成熟且重要的市場，其特點是眼科專業人員意識高、臨床通訊協定完善、兒童近視控制方面應用廣泛，這得益於主要製造商的存在和先進的眼科護理基礎設施。

同時，亞太地區是規模最大且成長最快的市場。這直接歸因於中國、日本、韓國和台灣等國家和地區近視盛行率極高且呈上升趨勢。文化因素、對學業成就的重視以及家長對近視管理投入的不斷增加，都推動了角膜塑形術的快速普及，使亞太地區成為該領域規模和創新都十分集中的中心。

競爭格局與策略重點

市場由專業鏡片製造商和設有角膜塑形鏡部門的大型隱形眼鏡公司組成。競爭主要集中在鏡片設計技術、用於維持夜間佩戴時角膜健康的材料滲透性（DK值）、驗配軟體的先進程度以及對眼科專業人員的臨床支持等方面。

策略發展重點在於改善近視預防。各公司正增加最佳化周邊離焦鏡片設計的研發投入，以期減緩眼球生長。他們也不斷創新鏡片材料，以提高透氧滲透性和舒適度。關鍵趨勢包括開發整合式數位化解決方案，例如先進的角膜地形圖設備和人工智慧驅動的驗配軟體，這些方案能夠提高驗配的準確性、可預測性和效率。此外，專業教育和認證課程也是擴大合格人才儲備、推動市場成長的重要策略工具。

市場展望

角膜塑形鏡市場預計將保持強勁且持續的成長，主要驅動力是近視矯正和預防的雙重需求。這一成長軌跡與公共衛生部門為應對近視流行而採取的措施以及專業人士對角膜塑形鏡作為一線治療方案日益成長的認可密切相關。

未來的發展趨勢將是利用數千次驗配的巨量資料，為每位患者量身訂製鏡片，從而最佳化治療效果。將感測器技術應用於依從性監測是未來的發展方向。儘管成本和普及程度仍然存在障礙，但其顯著的臨床益處，尤其是在兒童中，足以推動市場擴張。

成功與否取決於製造商能否透過長期研究證明其產品在近視控制方面具有卓越功效，能否提高治療的成本效益和可及性，以及能否持續為眼科專業人員提供更先進的工具和培訓。角膜塑形術具有獨特的可逆性和非手術治療優勢，已穩固確立其在屈光不正綜合治療方法中的重要地位，尤其是在兒童這一關鍵人群中。

本報告的主要優勢：

• 深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要企業的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
• 市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
• 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
• 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

• 2022年至2024年的歷史數據和2025年至2031年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區（包括國家）分類的收入和預測評估
• 公司概況（策略、產品、財務資訊）及主要發展動態。

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

第5章 依產品類型分類的角膜塑形鏡市場

• 介紹
• 日間角膜塑形鏡
• 夜間角膜塑形鏡

第6章 依適應症分類的角膜塑形鏡市場

• 介紹
• 近視
• 老花眼
• 遠見
• 散光

第7章 依分銷管道分類的角膜塑形鏡市場

• 介紹
• 醫院
• 眼科診所
• 眼科
• 其他

第8章 各地區角膜塑形鏡市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第10章：公司簡介

• Bausch & Lomb Inc.
• Euclid Systems Corp.
• CooperVision
• John & Johnson Vision Care
• Alpha Corporation
• Brighten Optix
• GP Specialists
• TruForm Optics
• Art Optical Contact Lens
• MiracLens LLC

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

The orthokeratology lens market is forecasted to rise at a 6.23% CAGR, reaching USD 1251.21 million in 2031 from USD 870.785 million in 2025.

The orthokeratology (Ortho-K) lens market is a specialized and growing niche within the broader contact lens and vision correction industry, focused on the design, manufacture, and fitting of rigid gas permeable (RGP) contact lenses worn overnight. These lenses are engineered to temporarily reshape the curvature of the cornea through a controlled molding process, providing clear, glasses-free vision during waking hours after the lenses are removed. Primarily used for the correction of myopia (nearsightedness), and to a lesser extent hyperopia and astigmatism, orthokeratology offers a non-surgical, reversible alternative to laser surgery. The market is experiencing significant growth, driven by the rising global prevalence of myopia, increasing patient preference for non-surgical options, and the unique value proposition of Ortho-K for myopia control in children, which has become a major clinical application.

Core Technology and Mechanism of Action

Orthokeratology utilizes reverse geometry lens designs. Unlike standard contact lenses that correct vision by altering light refraction directly on the eye, Ortho-K lenses apply a gentle, programmed pressure to the central cornea during sleep. This temporary redistribution of epithelial cells flattens the central optical zone, reducing myopic refractive error. The effect is not permanent; corneal elasticity causes it to gradually revert to its original shape, typically requiring nightly wear to maintain corrected vision. The process is carefully managed by eye care professionals through a series of fittings and follow-up assessments to ensure safety, efficacy, and optimal visual outcomes.

A critical and expanding application is myopia control or management. Clinical studies have demonstrated that certain Ortho-K lens designs can effectively slow the progression of myopia in children and adolescents. This has positioned Ortho-K as a leading therapeutic option for managing pediatric myopia, addressing a major concern among parents and eye care practitioners regarding rising myopia rates and associated long-term ocular health risks.

Key Market Drivers

The dominant driver is the global increase in the prevalence of myopia, particularly among children and young adults. Epidemiological trends, often linked to lifestyle factors like increased near-work and reduced time outdoors, have created a larger patient population seeking correction. This "myopia boom" is especially pronounced in Asia-Pacific but is a worldwide phenomenon.

Closely linked is the growing demand for myopia control solutions. As awareness of the risks associated with high myopia (such as retinal detachment, glaucoma, and myopic maculopathy) increases among eye care professionals and parents, Ortho-K is being actively adopted as a primary intervention to slow axial elongation in children, driving both new fittings and recurring lens replacement cycles.

Furthermore, patient preference for non-surgical and reversible vision correction is a significant factor. Ortho-K appeals to individuals who are unsuitable for or averse to refractive surgery (like LASIK), including younger patients, those with thin corneas, or individuals in professions where surgery is contraindicated. The convenience of glasses-free daytime vision is a major lifestyle benefit.

The aging global population also contributes, as presbyopia (age-related near vision loss) combines with existing refractive errors, creating complex vision correction needs that can sometimes be addressed with specialized multifocal Ortho-K designs.

Market Challenges and Restraints

A primary barrier to broader adoption is the high initial cost and ongoing expense associated with treatment. The process involves specialized diagnostic equipment, professional fitting fees, and the cost of the lenses themselves, which is significantly higher than that of standard soft contact lenses. This can limit access, particularly in price-sensitive markets or where insurance coverage is absent.

The treatment requires a high degree of patient compliance and professional expertise. Successful outcomes depend on consistent overnight wear and meticulous lens hygiene to mitigate risks, such as microbial keratitis. The fitting process is more complex and time-intensive than standard contact lens fittings, requiring practitioners with specific training and experience, which can constrain the pool of prescribing doctors.

Regional Market Dynamics

North America is a mature and leading market, characterized by high awareness among eye care professionals, established clinical protocols, and significant adoption for pediatric myopia control. The presence of key manufacturers and advanced eye care infrastructure supports its dominance.

The Asia-Pacific region, however, represents the largest and fastest-growing market. This is directly attributable to the exceptionally high and rising prevalence of myopia in countries like China, Japan, South Korea, and Taiwan. Cultural factors, strong emphasis on academic achievement, and growing parental investment in myopia management have driven rapid adoption of Ortho-K, making APAC the epicenter of both volume and innovation in the space.

Competitive Landscape and Strategic Focus

The market consists of specialized lens manufacturers and larger contact lens companies with dedicated Ortho-K divisions. Competition centers on lens design technology, material permeability (DK value) for overnight corneal health, fitting software sophistication, and clinical support for eye care practitioners.

Strategic development is intensely focused on advancing myopia control efficacy. Companies invest in R&D for lens designs that optimize the peripheral defocus believed to slow eye growth. There is also innovation in lens materials to enhance oxygen transmissibility and comfort. A major trend is the development of integrated digital solutions, including advanced topographers and AI-powered fitting software to improve fitting accuracy, predictability, and efficiency. Furthermore, professional education and certification programs are critical strategic tools to expand the base of qualified practitioners and drive market growth.

Market Outlook

The orthokeratology lens market is poised for robust, sustained growth, primarily fueled by the dual demand for myopia correction and control. Its trajectory is closely tied to public health initiatives addressing the myopia epidemic and increasing professional endorsement of Ortho-K as a first-line management strategy.

Future evolution will be marked by personalized lens designs leveraging big data from thousands of fittings to optimize outcomes. The potential integration of sensor technology for compliance monitoring is an emerging frontier. While cost and access barriers persist, the compelling clinical benefits, especially for children, ensure the market's expansion.

Success will depend on manufacturers' ability to demonstrate superior myopia control outcomes through long-term studies, improve the cost-effectiveness and accessibility of the treatment, and continue to empower eye care professionals with superior tools and training. As a reversible, non-surgical option with a unique therapeutic benefit, orthokeratology is solidifying its role as a vital modality in the comprehensive management of refractive error, particularly within the critical pediatric demographic.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Key Segment:

• By Product Type
• Day-time Ortho-K Lenses
• Overnight Ortho-K Lenses
• By Indication
• Myopia
• Presbyopia
• Hypermetropia
• Astigmatism
• By Distribution Channel
• Hospitals
• Optometry Clinics
• Ophthalmology
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ORTHOKERATOLOGY LENS MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Day-time Ortho-K Lenses
• 5.3. Overnight Ortho-K Lenses

6. ORTHOKERATOLOGY LENS MARKET BY INDICATION

• 6.1. Introduction
• 6.2. Myopia
• 6.3. Presbyopia
• 6.4. Hypermetropia
• 6.5. Astigmatism

7. ORTHOKERATOLOGY LENS MARKET BY DISTRIBUTION CHANNEL

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Optometry Clinics
• 7.4. Ophthalmology
• 7.5. Others

8. ORTHOKERATOLOGY LENS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Bausch & Lomb Inc.
• 10.2. Euclid Systems Corp.
• 10.3. CooperVision
• 10.4. John & Johnson Vision Care
• 10.5. Alpha Corporation
• 10.6. Brighten Optix
• 10.7. GP Specialists
• 10.8. TruForm Optics
• 10.9. Art Optical Contact Lens
• 10.10. MiracLens L.L.C.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations